相关实验视频

Updated: Jan 12, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

传染病病病毒 (IBDV) 作为一种新的瘤性病毒疗法,用于质母细胞瘤

Vicent Tur-Planells^1,2,3, Yonina Bykov¹, Gloria Dawodu¹

¹Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Journal for immunotherapy of cancer

|November 5, 2025

概括

传染性病病毒 (IBDV) 显示出作为一种新型质母细胞瘤 (GBM) 病毒疗法的前景. 这种瘤病毒有效地向GBM细胞,增强化疗,并重塑瘤微环境以改善结果.

科学领域:

神经瘤学神经瘤学
病毒学病毒学
免疫治疗是一种免疫疗法.

背景情况:

质母细胞瘤 (GBM) 是一种具有侵略性的脑癌,由于其免疫抑制的微环境,治疗结果有限.
传统疗法和免疫疗法面临着GBM耐药性和瘤微环境抑制的挑战.
针对GBM正在探索瘤病毒,提供瘤特异性复制和免疫刺激.

研究的目的:

调查传染病病毒 (IBDV) 作为质母细胞瘤病毒疗法的潜力.
在临床前的GBM模型中评估IBDV的疗效.

主要方法:

在实验室中使用小鼠和患者衍生的GBM细胞进行研究.
在GBM的同源性小鼠模型中的体内研究.
对瘤免疫微环境变化的分析.
在人体GBM实验中进行了ex vivo实验.

主要成果:

感染IBDV并在GBM细胞中复制,引起瘤溶解并激活炎症基因表达.
IBDV增强了泰莫索洛米德 (TMZ) 化疗的疗效.
在体内,IBDV减少了瘤生长,并改善了小鼠的存活率.
IBDV治疗调节了瘤免疫微环境,减少了免疫抑制细胞,增加了细胞毒性T细胞.

结论:

在GBM模型中,IBDV在GBM模型中表现出性活性和免疫调节效应.
这些发现支持进一步调查IBDV作为对GBM的潜在病毒治疗剂.

关键词:

中枢神经系统癌症中枢神经系统癌症免疫治疗是一种免疫疗法.在瘤内,口腔内.瘤学病毒病毒.瘤微环境 - - 瘤微环境

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma

Published on: November 15, 2024

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...